Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
13976
CALL
Codexis
CDXS
$147M
| $308 | ﹤0.01% |
100
-7,800
| -99% | -$24.1K |
2022 Q4
7 quarters
|
|
|
13977
PUT
Codexis
CDXS
$147M
| $308 | ﹤0.01% |
100
-100
| -50% | -$309 |
2022 Q3
8 quarters
|
|
13978
CALL
Milestone Pharmaceuticals
MIST
$97.9M
| $304 | ﹤0.01% |
200
-15,700
| -99% | -$22.8K |
2023 Q1
6 quarters
|
|
|
SRTA
13979
CALL
Strata Critical Medical Inc
SRTA
$423M
| $294 | ﹤0.01% |
100
-10,500
| -99% | -$33.4K |
2021 Q1
14 quarters
|
|
|
EDBLW
13980
Edible Garden AG Warrant
EDBLW
$76.7K
| $293 | ﹤0.01% |
30,854
+1,006
| +3% | +$18 |
2023 Q1
6 quarters
|
|
13981
PUT
Nautilus Biotechnolgy
NAUT
$260M
| $285 | ﹤0.01% |
100
-400
| -80% | -$1.03K |
2023 Q1
6 quarters
|
|
|
GURE
13982
PUT
Gulf Resources
GURE
$5.44M
| $284 | ﹤0.01% |
30
-160
| -84% | -$1.73K |
2023 Q4
3 quarters
|
|
|
OCFT
13983
PUT
DELISTED
OneConnect Financial Technology
OCFT
| $280 | ﹤0.01% |
+100
| New | +$150 |
2024 Q3
0 quarters
|
|
13984
CALL
Sagimet Biosciences
SGMT
$634M
| $277 | ﹤0.01% |
100
-900
| -90% | -$2.77K |
2024 Q2
1 quarter
|
|
13985
PUT
Lyell Immunopharma
LYEL
$223M
| $276 | ﹤0.01% |
10
-365
| -97% | -$10.7K |
2022 Q4
7 quarters
|
|
|
GP
13986
PUT
GreenPower Motor Co
GP
$5.44M
| $274 | ﹤0.01% |
20
+10
| +100% | +$109 |
2024 Q2
1 quarter
|
|
13987
CALL
5E Advanced Materials
FEAM
$161M
| $270 | ﹤0.01% |
22
-217
| -91% | -$4.11K |
2024 Q2
1 quarter
|
|
13988
CALL
Spero Therapeutics
SPRO
$68.1M
| $268 | ﹤0.01% |
200
-300
| -60% | -$402 |
2024 Q2
1 quarter
|
|
|
13989
PUT
Spero Therapeutics
SPRO
$68.1M
| $268 | ﹤0.01% |
200
-800
| -80% | -$1.07K |
2024 Q2
1 quarter
|
|
13990
PUT
SES AI
SES
$312M
| $256 | ﹤0.01% |
400
-500
| -56% | -$522 |
2021 Q4
11 quarters
|
|
13991
PUT
TELA Bio
TELA
$52.4M
| $253 | ﹤0.01% |
100
-1,000
| -91% | -$3.56K |
2024 Q1
2 quarters
|
|
13992
PUT
CBAK Energy Technology Ltd
CBAT
$120M
| $250 | ﹤0.01% |
200
-100
| -33% | -$112 |
2024 Q1
2 quarters
|
|
|
XBPEW
13993
XBP Europe Holdings Warrant
XBPEW
| $245 | ﹤0.01% |
+12,269
| New | +$396 |
2024 Q3
0 quarters
|
|
13994
Global X MSCI China Consumer Discretionary ETF
CHIQ
$99.6M
| $236 | ﹤0.01% |
+11
| New | +$184 |
2024 Q3
0 quarters
|
|
|
NLSPW
13995
DELISTED
NLS Pharmaceutics Warrant
NLSPW
| $224 | ﹤0.01% |
19,626
+3,618
| +23% | +$106 |
2024 Q2
1 quarter
|
|
|
VMEO
13996
DELISTED
Vimeo
VMEO
| $222 | ﹤0.01% |
44
-47
| -52% | -$213 |
2021 Q2
13 quarters
|
|
|
DFNSW
13997
T3 Defense Inc Warrants
DFNSW
$436K
| $215 | ﹤0.01% |
23,322
+861
| +4% | +$17 |
2024 Q1
2 quarters
|
|
13998
PUT
Presidio Property Trust
SQFT
$1.74M
| $215 | ﹤0.01% |
30
-100
| -77% | -$684 |
2024 Q2
1 quarter
|
|
13999
Hub Cyber Security Warrant
HUBCZ
| $214 | ﹤0.01% |
71,463
+9,695
| +16% | +$75 |
2023 Q2
5 quarters
|
|
|
RFACW
14000
DELISTED
RF Acquisition Corp. Warrants
RFACW
| $213 | ﹤0.01% |
10,554
| – | – |
2023 Q1
6 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.